Shareholders that lost money on LifeMD, Inc. (LFMD) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More

Core Viewpoint - A class action securities lawsuit has been filed against LifeMD, Inc. for alleged securities fraud affecting investors between May 7, 2025, and August 5, 2025 [1][2] Group 1: Allegations - The lawsuit claims that defendants materially overstated LifeMD's competitive position [2] - It is alleged that defendants were reckless in raising LifeMD's 2025 guidance without properly accounting for rising customer acquisition costs in the RexMD segment and related to obesity treatment drugs [2] - Defendants' statements regarding LifeMD's business, operations, and prospects are claimed to be materially false and misleading [2] Group 2: Legal Process - Investors who suffered losses during the specified timeframe have until October 25, 2025, to request appointment as lead plaintiff [3] - Participation in the lawsuit does not require serving as a lead plaintiff, and there are no out-of-pocket costs for class members [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the U.S. [4]